Lyon, France, 21 May 2013 – The International Agency for Research on Cancer (IARC) has the pleasure of announcing the re-election of Dr Christopher Wild as Director of this specialized cancer research agency of the World Health Organization (WHO). The IARC Governing Council, made up of representatives of 24 Participating States plus the Director-General of WHO, reappointed Dr Wild for a second five-year term at its annual meeting in Lyon on May 16–17, 2013.
“I have had the honour and privilege to lead IARC for five years, and I look forward to taking up the challenges posed by the markedly increasing number of cancer cases globally,” said Dr Wild. “The particularly heavy burden projected to fall on the low- and middle-income …
Global Health programs are key goals of many internationally oriented Health Institutes and Organizations, and within such approach a Global Oncology program will become a major, crucial objective.
Infectious diseases are in general under control (with some emerging and re-emerging episode), life expectancy is globally increasing, and incidence as well as disease-burden of cancers (associated or not to infectious agents) will be inevitably rising. We need to develop the new clinical oncology of tomorrow and to prepare the next generation of oncologists. The aims of the section and the call for the papers is currently highlighted at the BioMed Central Blog
It is unusual for the IAC blog to have a post from cancer patients. However, to see the other side of the story, and to verify first hand how much effective a cancer treatment can be and how grateful patients and their families are to the scientific community, can be relevant for motivating young scientists and physicians in their daily struggle to identify pathogenic mechanisms, improve early diagnosis, discover therapeutic targets. The following post has just been received by Mr Cameron Von St. James.
November 21, 2005 will forever stand out in my memory as the day when my life fell apart. My wife, Heather, had been told that she suffered from malignant pleural mesothelioma on that day. …
I do not know how popular is the English version of the Latin motto Lupus pilum mutat, non mentem, in Italian, however, it is very frequently used and even with a negative or a positive meaning. The negative component is emphasized for vices, which cannot be easily abandoned; the positive component is a strong determination, motivated stubbornness.
Last week the Latin motto with the positive meaning came to my mind at the end of the Lectio Magistralis on The role of pathogens in human cancers, held on Friday April 12th at Istituto Nazionale Tumori “Fond Pascale” Naples-IT, by the Nobel Laureate Prof. Dr. Harald zur Hausen. A Nobel Laureate in Medicine (2008), retired almost 10 years ago, could be just …
A new short video has just been released highlighting Burkitt Lymphoma and EMBLEM activities in this area, including information on the Workshop in Mwanza last September.
The video was a collaborative project bringing local groups together to empower and recognize people who are working in the Burkitt Lymphoma area. The animation in the video was completed by students.
GVN’s Three Action Platforms
1. Support for cutting edge research
GVN supports its scientists through small grants that allow new lines of research to move forward. To ensure that medical virologists are in place to address future, yet unimagined viral challenges, GVN provides training fellowships for tomorrow’s leaders. GVN scientists share ideas and information to avoid duplicative research. And, in outbreak situations, GVN experts stand ready to provide critical insights that will be integral for containment and prevention measures.
2. Public education
GVN provides authoritative science-driven information to the public and policymakers about viruses and vaccines through a spectrum of outreach initiatives and digital forums.
GVN works with governments and research funding agencies worldwide to ensure …
The 28th International Papillomavirus Conference and Clinical and Public Health Workshops is going to be held in San Juan (Puerto Rico) on Nov 30-Dec 6, 2012.
The event will be held at the Puerto Rico Convention Center the newest, largest and most advanced Convention Center in the Caribbean, architecturally dynamic in structure and with spacious areas that will facilitate the interaction among participants.
The 28th International Papillomavirus (IPV) Conference Organizing Committee is planning a scientific program addressing the most recent advances across the spectrum of HPV research from basic sciences to public health. The goal is to provide a forum for the exchange of new knowledge; the discussion of the status of HPV research and its future direction; and the discussion of …
The third Global Virus Network Meeting is going to be held in Naples from 07 to 09 June.
The GVN was established in March 2011at the Italian Embassy in Washington DC by Drs. Robert Gallo of the Institute of Human Virology in Baltimore, Reinhard Kurth, of the Robert Koch Institute Berlin, and William Hall, of University College Dublin, along with over 30 other leading medical virologists representing nearly two dozen countries, including Argentina, Canada, China, Germany, India, Ireland, Israel, Italy, Japan, Russia (in collaboration with Azerbaijan, Belarus, Estonia, Georgia, Latvia, Lithuania, Uzbekistan, and Ukraine), South Africa, Spain, Sweden, the United Kingdom, and the United States. This list is growing with several additional GVN centers in formation.
Dr. Luigi Chieco-Bianchi, Drs. …
The second Meeting on Emerging Oncogenic Viruses was held from May 30th to June 3rd in in San Pietro in Bevagna, Manduria, Province of Taranto, Puglia, South Italy.
The meeting has been organized following the success of the first meeting in 2010, as well as the very favourable and enthusiastic feedback from the some 120 scientists who attended the first Meeting.
It has been co-organized and sponsored by the International Agency for Research on Cancer (IARC) and Deutsches Krebsforschungszentrum (DKFZ) and was intended for basic researchers (biologists and epidemiologists), as well as clinicians.
The objectives of the meeting was the discussion and critical evaluation of epidemiology, immunology and biology of cancer-associated viruses. The meeting programme mainly emphasised new HPV-related cancers and newly-discovered …
On January 24th an editorial entitled Supporting the advancement of science: Open access publishing and the role of mandates, written by Lisa Phelps, Bernard Fox and Francesco M Marincola, has been published on Journal of Translational Medicine (JTM). It deals with a very relevant issue which could undermine the survival of the Open Access system: the introduction of a new bill at the United States House of Representatives,the Research Works Act (H.R.3699).
Open Access information is a key factor for fast and global diffusion of knowledge, a relevant aspect for socio-cultural matters, but extremely crucial for life science and public health issues. The global village we live in needs global information. If barriers are not able to stop HIV/AIDS sexual spreading …